In February 2016 the Falsified Medicines Directive and Delegated Regulation came into force. The purpose is to protect patients from acquisition of falsified medicines through a legal supply chain in the countries of the European Union and the European Economic Area.

The Directive and the Delegated Regulation refer to prescription medicines, the packaging of which is containing unique safety features, and to certain medicines not subject to prescription.

The Regulation determines the procedure, according to which the safety signs are verified and the unique identifier is deleted by wholesalers, producers and person, which are permitted or entitled to supply inhabitants with medicines.

Decommission the unique identifier at the time of supplying to the public

Unique identifier
on each package
Repositories system
Verification upon
dispense to patients